Form 424B5 ProPhase Labs Inc For: 6 February
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ProPhase Labs Inc (PRPH)
Track the ProPhase Labs share price today and view real-time PRPH share price data, including charts, technicals, and key financials. View the PRPH premarket stock price ahead of the market session or assess the after hours quote. Explore PRPH stock price movements, trading volume, and market activity across the OTC exchange.
What Is the ProPhase Labs Stock Price Today?
The ProPhase Labs stock price today is 0.128.
What Is the Stock Symbol for ProPhase Labs?
The stock symbol for ProPhase Labs is ""PRPH.""
What Stock Exchange Does ProPhase Labs Trade On?
ProPhase Labs is listed and trades on the OTC Markets stock exchange.
Is ProPhase Labs a Good Stock to Buy?
Determining whether ProPhase Labs or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRPH quote. (ISIN: US74345W2070)
What Is the ProPhase Labs Stock Price Today?
The ProPhase Labs stock price today is 0.128.
What Is the Stock Symbol for ProPhase Labs?
The stock symbol for ProPhase Labs is ""PRPH.""
What Stock Exchange Does ProPhase Labs Trade On?
ProPhase Labs is listed and trades on the OTC Markets stock exchange.
Is ProPhase Labs a Good Stock to Buy?
Determining whether ProPhase Labs or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRPH quote. (ISIN: US74345W2070)
OTC Markets
Currency in USD
0.128
+0.022(+20.72%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.106
0.140
52 wk Range
0.068
6.659
PRPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1060.140
52 wk Range
0.0686.659
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PRPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Form 8K ProPhase Labs Inc For: 19 December
- Investing.com
- Form 8K ProPhase Labs Inc For: 27 January
- Investing.com
- Form 424B5 ProPhase Labs Inc For: 6 February
- Investing.com
- Form 8K ProPhase Labs Inc For: 27 January
- Investing.com
- Form 8K ProPhase Labs Inc For: 23 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
ProPhase Labs Inc Earnings Call Summary for Q3/2025
- ProPhase Labs reported Q3 2025 EPS of -$0.16 (missing -$0.11 forecast) and revenue of $880,000 (84.53% below expectations), yet saw stock rise 6.59% to $0.275 premarket.
- Despite financial constraints, the company anticipates a $50 million net cash influx from Crown Medical Collections and projects a tenfold increase in value within 18 months.
- CEO Ted Karkus expressed confidence in the B-Smart Esophageal Cancer Test, claiming it 'should be worth $1 billion' within three to four years.
- The company has paused its crypto treasury strategy to focus on core business initiatives, including strategic mergers and acquisitions.
- Management addressed potential reverse stock split plans during Q&A, highlighting the disconnect between asset value and current $12 million market capitalization.
Last Updated: 20/11/2025, 07:28 am
Read Full TranscriptCompare PRPH to Peers and Sector
Metrics to compare | PRPH | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipPRPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.3x | −0.4x | |
PEG Ratio | 0.00 | 0.10 | 0.00 | |
Price/Book | 0.1x | 4.3x | 2.6x | |
Price / LTM Sales | 0.1x | 1.0x | 3.2x | |
Upside (Analyst Target) | - | 257.4% | 51.5% | |
Fair Value Upside | Unlock | 15.6% | 6.8% | Unlock |
Earnings
Latest Release
01/04/2026
EPS / Forecast
-- / -0.12
Revenue / Forecast
-- / 9.67M
People Also Watch
FAQ
What Is the ProPhase Labs (PRPH) Stock Price Today?
The ProPhase Labs stock price today is 0.128 USD.
What Stock Exchange Does ProPhase Labs Trade On?
ProPhase Labs is listed and trades on the OTC Markets.
What Is the Stock Symbol for ProPhase Labs?
The stock symbol for ProPhase Labs is "PRPH."
What Is the ProPhase Labs Market Cap?
As of today, ProPhase Labs market cap is 645.880K USD.
What Is ProPhase Labs's Earnings Per Share (TTM)?
The ProPhase Labs EPS (TTM) is -13.820.
When Is the Next ProPhase Labs Earnings Date?
ProPhase Labs will release its next earnings report on 01/04/2026.
From a Technical Analysis Perspective, Is PRPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has ProPhase Labs Stock Split?
ProPhase Labs has split 3 times.
What is the current trading status of ProPhase Labs (PRPH)?
As of 13/04/2026, ProPhase Labs (PRPH) is trading at a price of 0.128 USD, with a previous close of 0.106 USD. The stock has fluctuated within a day range of 0.106 USD to 0.140 USD, while its 52-week range spans from 0.068 USD to 6.659 USD.
What Is the PRPH After Hours Price?
PRPH's last after hours stock price is 0.090 USD, the stock has decreased by -0.013, or -12.240%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.